Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use

Inclusion Criteria: * Current patient of CHA primary care or behavioral health provider * Active enrollment in CHA MindWell * Sufficient English fluency to understand procedures and questionnaires * Ability to provide informed consent * Access to the internet and an electronic device to attend study groups and complete questionnaires. * CAT-DI 50-75 Exclusion Criteria: * Active psychosis or severe level of psychosis on PSY-S-CAT ≥60 * Bipolar I disorder history or severe level of mania on CAT-M/H50 (\>70) * Acute suicidality or self-injurious behavior or severe level of suicidality on CAT-SS(≥71) * Severe depression, indicated by CAT-DI PHQ-9 equivalency score \>20 * Severe level of PTSD on CAT-PTSD (\>70) * Current treatment with antipsychotic medication, mood stabilizer or benzodiazepine equivalent of 3mg/day of lorazepam * Cognitive inability as demonstrated by the inability to complete an online informed consent assessment * Current participation in another experimental research study * Previous participation in an 8-week intensive Mindfulness-Based Intervention in past 1 year * Expected medical hospitalization in next 6 months * Expected incarceration in next 6 months * Severe substance use disorder or high risk on CAT-MH SUD. In addition, use of or positive toxicology for cocaine, unprescribed opioids, stimulants, or benzodiazepines in the past 3 months. * Inability to participate in group intervention without disrupting group in opinion of principal investigator * I…